Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
26 Cards in this Set
- Front
- Back
|
platelets
|
100k-450k
|
|
|
uric acid
|
2-8 mg/dl
|
|
|
LDH
|
56-194 IU/L
|
|
|
WBC
|
4500-10000
|
|
|
Hgb
|
12-16.5 (males>females)
|
|
|
CEA
|
tumor marker colon cancer
|
|
|
CA125
|
tumor marker for ovarian cancer
|
|
|
Calcium
|
8.5-10.5 mg/dl
|
|
|
Potassium
|
3.5-5.2 meq/L
|
|
|
Albumin
|
3.2-5 g/dl
|
|
|
bilirubin
|
0.1-1.2 mg/dl
|
|
|
magnesium
|
1.6-2.4 mEq/L
|
|
|
sodium
|
135-147 mEq/L
|
|
|
ferritin
|
13-300 ng/ml
|
|
|
transferrin
|
>200 mg/dl
|
|
|
total iron binding capacity (TIBC)
|
250-420 mcg/dl
|
|
|
segmented neutrophils
|
54% - 62%
|
|
|
bands
|
3 -5%
|
|
|
basophils
|
0-1 (0-0.75%)
|
|
|
eosinophils
|
0-3 (1-3%)
|
|
|
lymphocytes
|
24-44 (25-33%)
|
|
|
monocytes
|
3-6 (3-7%)
|
|
|
p53
|
tumor suppressor gene
inactivation, mutation, or loss/downregulated expression= increased cancer risk |
|
|
BRCA1 & BRCA2
|
tumor suppressor genes
mutation carriers = increased risk of cancers, incl breast & ovarian |
|
|
Oncotype DX
|
The Oncotype DX assay is recommended for use in newly diagnosed ER+, N- breast cancer patients to predict risk of recurrence. The assay can also be used to identify patients who may be successfully treated with tamoxifen and may not require adjuvant chemotherapy
Low score <18 = good, low risk of recurrence Intermediate = 18-30 High risk = 19+ |
|
|
Ki-67
|
tumor marker to evaluate proliferative status of tumor
|
